Private Trust Company’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$552K Buy
6,474
+7
+0.1% +$624 0.05% 407
2025
Q4
$511K Sell
6,467
-947
-13% -$74.2K 0.04% 428
2025
Q3
$593K Sell
7,414
-281
-4% -$24K 0.05% 372
2025
Q2
$699K Sell
7,695
-211
-3% -$19.3K 0.07% 314
2025
Q1
$741K Sell
7,906
-1,776
-18% -$159K 0.08% 283
2024
Q4
$880K Sell
9,682
-1,655
-15% -$158K 0.09% 245
2024
Q3
$1.18M Sell
11,337
-44
-0.4% -$4.49K 0.12% 191
2024
Q2
$1.1M Buy
11,381
+186
+2% +$17.2K 0.12% 198
2024
Q1
$1.01M Buy
11,195
+399
+4% +$33.8K 0.11% 216
2023
Q4
$861K Sell
10,796
-6
-0.1% -$451 0.1% 231
2023
Q3
$768K Sell
10,802
-6,899
-39% -$516K 0.1% 231
2023
Q2
$1.36M Buy
17,701
+208
+1% +$16.1K 0.17% 129
2023
Q1
$1.31M Buy
17,493
+152
+0.9% +$11.3K 0.18% 126
2022
Q4
$1.37M Sell
17,341
-780
-4% -$58.5K 0.2% 108
2022
Q3
$1.27M Sell
18,121
-1,073
-6% -$84.1K 0.21% 108
2022
Q2
$1.54M Sell
19,194
-14,619
-43% -$1.14M 0.24% 99
2022
Q1
$2.56M Sell
33,813
-619
-2% -$49K 0.4% 68
2021
Q4
$2.94M Sell
34,432
-1,746
-5% -$136K 0.41% 65
2021
Q3
$2.73M Buy
36,178
+9,650
+36% +$766K 0.4% 64
2021
Q2
$2.16M Sell
26,528
-578
-2% -$47.3K 0.33% 93
2021
Q1
$2.14M Buy
27,106
+163
+0.6% +$12.8K 0.35% 84
2020
Q4
$2.3M Buy
26,943
+765
+3% +$63.3K 0.39% 76
2020
Q3
$2.02M Buy
26,178
+230
+0.9% +$17.5K 0.39% 68
2020
Q2
$1.91M Buy
25,948
+1,357
+6% +$96.4K 0.4% 67
2020
Q1
$1.63M Sell
24,591
-355
-1% -$25K 0.42% 66
2019
Q4
$1.72M Buy
24,946
+212
+0.9% +$14.5K 0.32% 85
2019
Q3
$1.82M Buy
24,734
+816
+3% +$59.2K 0.36% 77
2019
Q2
$1.71M Sell
23,918
-261
-1% -$18.5K 0.35% 79
2019
Q1
$1.66M Buy
24,179
+317
+1% +$20.5K 0.34% 77
2018
Q4
$1.42M Sell
23,862
-1,537
-6% -$96.2K 0.34% 80
2018
Q3
$1.7M Sell
25,399
-611
-2% -$40.7K 0.35% 73
2018
Q2
$1.69M Buy
26,010
+225
+0.9% +$14.7K 0.37% 71
2018
Q1
$1.85M Sell
25,785
-671
-3% -$48.3K 0.4% 62
2017
Q4
$2M Sell
26,456
-130
-0.5% -$9.49K 0.42% 60
2017
Q3
$1.94M Sell
26,586
-499
-2% -$36K 0.42% 63
2017
Q2
$2.01M Buy
27,085
+597
+2% +$44.3K 0.44% 59
2017
Q1
$1.94M Sell
26,488
-121
-0.5% -$8.47K 0.45% 59
2016
Q4
$1.74M Buy
26,609
+400
+2% +$27.4K 0.42% 64
2016
Q3
$1.94M Sell
26,209
-5
-0% -$370 0.47% 55
2016
Q2
$1.92M Buy
26,214
+2,639
+11% +$188K 0.5% 56
2016
Q1
$1.67M Sell
23,575
-607
-3% -$40.4K 0.45% 62
2015
Q4
$1.61M Buy
24,182
+174
+0.7% +$11.6K 0.46% 65
2015
Q3
$1.52M Buy
24,008
+238
+1% +$15.5K 0.46% 65
2015
Q2
$1.55M Sell
23,770
-142
-0.6% -$9.63K 0.45% 67
2015
Q1
$1.66M Sell
23,912
-135
-0.6% -$9.33K 0.47% 60
2014
Q4
$1.66M Sell
24,047
-21,870
-48% -$1.48M 0.53% 51
2014
Q3
$3M Sell
45,917
-502
-1% -$33.1K 1.02% 14
2014
Q2
$3.17M Sell
46,419
-2
-0% -$134 1.03% 14
2014
Q1
$3.01M Sell
46,421
-392
-0.8% -$24.7K 1.14% 12
2013
Q4
$3.05M Sell
46,813
-4
-0% -$256 1.23% 11
2013
Q3
$2.78M Sell
46,817
-901
-2% -$53.4K 1.26% 10
2013
Q2
$2.73M Buy
+47,718
New +$2.83M 1.26% 11

Other funds holding CL

Private Trust Company's CL Position: Q1 2026 in Review

Private Trust Company increased its Colgate-Palmolive (CL) stake by 0.11% in Q1 2026, buying an estimated $624 and bringing the position to 6,474 shares worth $552K. The position accounts for 0.05% of the portfolio, ranked #407.

Private Trust Company first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.17M in Q2 2014. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Private Trust Company held 6,474 shares of Colgate-Palmolive worth $552K as of Q1 2026.
  • Private Trust Company bought 7 Colgate-Palmolive shares in Q1 2026, an estimated $624.
  • Colgate-Palmolive made up 0.05% of Private Trust Company's portfolio in Q1 2026, its #407 holding.
  • Private Trust Company first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Private Trust Company's Colgate-Palmolive position peaked at $3.17M in Q2 2014.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Private Trust Company's 13F filing for Q1 2026, filed 30 Apr 2026.